Tirzepatide is a cutting-edge dual GIP and GLP-1 receptor agonist that has rapidly gained global attention for its dual action in glycemic control and weight reduction. Originally developed for type 2 diabetes, Tirzepatide has also shown unprecedented results in medical weight loss protocols, making it a preferred choice in clinical and wellness settings.
At ShiLai™ Peptide Technologies, we are a global leader in peptide manufacturing and custom synthesis, offering GMP-grade Tirzepatide with full quality documentation (COA, HPLC, MS) and factory-direct supply. With over a decade of peptide production expertise, we are also the largest peptide manufacturer in China — serving peptide distributors, compounding pharmacies, research institutions, and metabolic health clinics worldwide.
Whether you’re a clinic looking for consistent quality, or a distributor sourcing high-purity Tirzepatide, ShiLai™ is your trusted partner in advanced peptide solutions.
ShiLai™Peptide Technologies
Copyright © 2025 ShiLai™Peptide Technologies - All Rights Reserved.
ShiLai™Peptide
ShiLai™ Peptide Technologies supplies peptides solely for laboratory research and industrial R&D. We do not support or condone any unauthorized or off-label use